SANJIVANI PARANTERAL
Back to All Ratios
|
SANJIVANI PARANTERAL Last 5 Year EBIT Margin History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| EBIT Margin(%) | 15.06 | 14.35 |
What is the latest EBIT Margin ratio of SANJIVANI PARANTERAL ?
| Year | EBIT Margin |
|---|---|
| Mar2025 | 15.06 |
| Mar2024 | 14.35 |
How is EBIT Margin of SANJIVANI PARANTERAL Trending?
| Years | EBIT Margin | % Change | |
|---|---|---|---|
| Mar2025 | 15.06 | 4.95 | |
| Mar2024 | 14.35 | - | |
Other Financial Ratios of SANJIVANI PARANTERAL
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Margin ratio of peers of SANJIVANI PARANTERAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANJIVANI PARANTERAL | ₹229.9 Cr | -0.9% | 2.5% | -25.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,316.0 Cr | -2.7% | -3.7% | 20.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,737.0 Cr | 3.7% | 15.7% | 51% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,594.0 Cr | -0.8% | 1% | 36.2% | Stock Analytics | |
| CIPLA | ₹110,515.0 Cr | -2.1% | -5.2% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.6 Cr | -0.8% | -0.5% | -9.3% | Stock Analytics | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | -0.9% |
2.5% |
-25.3% |
| SENSEX | -2.4% |
-4.8% |
-7.2% |
You may also like the below Video Courses